Leveraging Experience to Reduce Timelines for IND-Enabling Activities
November 15, 2022
Tags:
Muctarr Sesay and Andrew Majdoch discuss how Goodwin Biotechnology's end-to-end capabilities, from RCBs to manufacturing, including fill/finish and stability studies help clients simplify the development process and reduce both costs and project timelines.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
